The “opiate receptor “has become a well-accepted entity, stimulating the search for an endogenous agonist. This has successfully revealed several different endogenous peptide opiates whose physiological role is under intense investigation, contributing to our understanding of pain and of opiate tolerance and dependence. A review of the current literature is presented.
References
1.
AkilH., MayerD. J., and LiebeskindJ. C. (1972): “Comparison Chez le Rat entre l'Analgésie Induite par Stimulation de la Substance Grise Péri-aqueducale et l'Analgésie Morphinique”, Comptes. Rend. Acad. Sci., 274, 3603.
2.
AvrovaN. F., ChenykaevaE. Y., and ObukhovaE. L. (1973): “Ganglioside Composition and Content of Rat-brain Subcellular Fractions”, J. Neurochem., 20, 997.
3.
BeckettA. H., and CasyA. F. (1954): “Synthetic Analgesics: Stereochemical Considerations”, J. Pharm. Pharmacol., 6, 986.
4.
BelluzziJ. D., GrantN., GarskyV., SarantakisD., WiseC. D., and SteinL. (1976): “Analgesia Induced in vivo by Central Administration of Enkephalin in Rat”, Nature, 260, 625.
5.
BradburyA. F., SmythD. G., SnellC. R., BirdsallN. J. M., and HulmeE. C. (1976): “C-fragment of Lipotropin has a High Affinity for Brain Opiate Receptors”, Nature, 260, 793.
6.
BraunT., HechterO., and LiC. H. (1970): The Endocrine Society, Fifty-second Meeting, 48.
7.
ChangJ., FongB. T. W., PertA., and PertC. B. (1976): “Opiate Receptor Affinities and Behavioural Effects of Enkephalin”, Life Sci., 18, 1473.
8.
CollierH. O. J. (1973): Proceedings 5th International, Congress in Pharmacology, 1, 65, In: Pharmacological Mechanisms of Drug Dependence, Karger, Basel.
9.
CollierH. O. J., and RoyA. C. (1974): “Morphinelike Drugs Inhibit the Stimulation by E Prostaglandins of Cyrclic AMP Formation by Rat Brain Homogenate”, Nature, 248, 24.
10.
CollierH. O. J., and FrancisD. L. (1975): “Morphine Abstinence is Associated with Increased Brain AMP”, Nature, 255, 159.
11.
CollierH. O. J., FrancisD. L., McDonald-GibsonW. J., RoyA. C., and SaeedS. A. (1975): “Prostaglandins, Cyclic AMP and the Mechanism of Opiate Dependence”, Life Sci., 17, 85.
12.
CoxB. M., OpheimK. E., TeschenmakerH., and GoldsteinA. (1975): “A Peptide-like Substance from Pituitary that Acts Like Morphine: 2. Purification and Properties”, Life Sci., 16, 1777.
13.
CoxB. M., GoldsteinA., and LiC. H. (1976): “Opioid Activity of a Peptide, β-lipotropin–(61–91), derived from β-lipotropin”, Proc. Nat. Acad. Sci. USA, 73, 1821.
14.
FrancisD. L., RoyA. C., and CollierH. O. J. (1975): “Morphine Abstinence and Quasi-abstinence Effects after Phosphodiesterase Inhibitors and Naloxone”, Life Sci., 16, 1901.
15.
FeldbergW., and SmythD. G. (1976): “The C-fragment of Lipotropin—A Potent Analgesic”, J. Physiol., 260, 30P.
16.
GeroA.,” and CapetolaR. J. (1975): “Plasma Cholinesterase and the Morphine Receptor”, Life Sci., 16, 1821.
17.
GeroA. (1976): “Inactivity of Enkephaline on Human Serum Esterase”, Life Sci., 19, 479.
18.
GoldsteinA., LowneyL. I., and PalB. K. (1971): “Stereospecific and Non-specific Interactions of the Morphine Congener Levorphanol in Subcellular Fractions of Mouse Brain”, Proc. Nat. Acad. Sci. USA, 68, 1742.
19.
GoldsteinA. (1974): “Opiate Receptors”, Life Sci., 14, 615.
20.
GoldsteinA. (1975): Proc. Int. Symp. Alc. ana Drug Res., Oct. 23–25, 1973. In: Biological and Behavioural Approaches to Drug Dependence, Addiction Research Foundation, Toronto.
21.
GoldsteinA., GoldsteinJ. S., and CoxB. M. (1975): “A Synthetic Peptide with Morphine-like Pharmacological Action”, Life Sci., 17, 1643.
22.
GoldsteinA., PryorG. T., OtisL. S., and LarsenF. (1976): “On the Role of Endogenous Opioid Peptides: Failure of Naloxone to Influence Shock Escape Threshold in the Rat”, Life Sci., 18, 599.
23.
HillerJ. M., PearsonJ., and SimonE. J. (1973): “Distribution of Stereo-specific Binding of the Potent Narcotic-analgesic Etorphine in the Human Brain: Predominence in the Limbic System”, Res. Commun. Chem. Pathol. Pharmacol., 6, 1052.
24.
HoltzmanS. G. (1974): “Behavioural Effects of Separate and Combined Administration of Naloxone and d-Amphetamine”, J. Pharmacol. Exp. Ther., 18951.
25.
HoltzmanS. G. (1975): “Effects of Narcotic-antagonists on Fluid Intake in the Rat”, Life Sci., 16, 1465.
26.
HornA. S., and RogersJ. R. (1976): “Structural and Conformational Relationships Between the Enkephalins and the Opiates”, Nature, 260, 795.
27.
HughesJ., KosterlitzH. W., and LeslieF. M. (1974): “Assessment of the Agonist and Antagonist Activities of Narcotic-analgesic Drugs by Means of the Mouse vas Deferens”, Brit. J. Pharmacol., 51, 139P.
28.
HughesJ. (1975): “Isolation of an Endogenous Compound from the Brain with Pharmacological Properties Similar to Morphine”, Brain Res., 88, 295.
29.
HughesJ., SmithT., MorganB., and FothergillL. (1975): “Purification and Properties of Enkephalin —the possible Endogenous Ligand for the Morphine Receptor”, Life Sci., 16, 1753.
30.
HughesJ., SmithT. W., KosterlitzH. W., FothergillL. A., MorganB. A., and MorrisH. R. (1975): “Identification of Two Related Pentapeptides From the Brain with Potent Opiate Agonist Activity”, Nature, 258, 577.
31.
JacobJ. J., TremblayE. C., and ColombelM. (1974): “Facilitation de Reactions Nociceptives par la Naloxone chez la Souris et chez le Rat”, Psychopharmacologia, 37, 217.
32.
JohnstonP. I., and RootsB. I. (1972): Nerve Membranes, p. 178, Pergamon Press, New York.
33.
KleeW. A., and StreatyR. A. (1974): “Narcotic Receptor Sites in Morphine-Dependent Rats”, Nature, 248, 61.
34.
KleeW. A., and NirenbergM. (1974): “A Neuroblastoma × Glioma Hybrid Cell Line with Morphine Receptors”, Proc. Nat. Acad. Sci. USA, 71, 3474.
35.
KleeW. A., and NirenbergM. (1976): “Mode of Action of Endogenous Opiate Peptides”, Nature, 263, 609.
36.
KosterlitzH. W., LordJ. A. H., and WattA. J. (1972): “Morphine Receptor in the Myenteric Plexus of the Guinea-pig Ileum “. In: KosterlitzH. W., CollierH. O. J., and VillarrealJ. E., Agonist and Antagonist Actions of Narcotic-Analgesic Drugs, p. 45, MacMillan, London.
37.
KosterlitzH. W., and HughesJ. (1975): “Some Thoughts on the Significance of Enkephalin, the Endogenous Ligand”, Life Sci., 17, 91.
38.
KuharM. J., PertC. B., and SnyderS. H. (1973): “Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain”, Nature, 245, 447.
39.
LeeC. Y., StolmanS., AkeraT., and BrodyT. M. (1973): “Saturable Binding of [3H]—Dihydromorphine to Rat Brain Tissue in vitro”, Pharmacologist, 15, 202.
40.
LiC. H., and ChungD. (1976): “Isolation and Structure of an Untriakontapeptide with Opiate Activity from Camel Pituitary Glands”, Proc. Nat. Acad. Sci. USA, 73, 1145.
41.
LiebeskindJ. C., GailbaudG., BessonJ. M., and OliverasJ. L. (1973): “Analgesia from Electrical Stimulation of the Periaquaductal Grey Matter in the Cat”, Brain Res., 50, 441.
42.
LiebeskindJ. C., MayerD. J., and AkilH. (1974): “Central Mechanisms of Pain Inhibition: Studies of Analgesia from Focal Brain Stimulation”, Advances in Neurology, Vol. 4, International Symposium on Pain, p. 261, Raven Press, New York.
43.
LohH. H., ChoT. M., WuY. C., and WayE. L. (1974): “Stereospecific Binding of Narcotics to Brain Cerebrosides”, Life Sci., 14, 2231.
44.
LohH. H., ChoT. M., WuY. C., HarrisR. A., and WayE. L. (1975): “Opiate Binding to Cerebroside Sulphate: A Model System for Opiate-receptor Interaction”, Life Sci., 16, 1811.
45.
LohH. H., TsengL. F., WeiE., and LiC. H. (1976): “β-endorphin is a Potent Analgesic Agent”, Proc. Nat. Acad. Sci. USA, 73, 2895.
46.
LowneyL. I., SchulzK., LoweryP. J., and GoldsteinA. (1974): “Partial Purification of an Opiate Receptor from Mouse Brain”, Science, 183, 749.
47.
MayerD. J., PriceD. D., RaffiA., and BarkerJ. (1976): Proceedings First World Congress on Pain, (In press).
48.
PasternakG. W., and SnyderS. H. (1975): “Identification of Novel High Affinity Opiate Receptor Binding in Rat Brain”, Nature, 253, 563.
49.
PasternakG. W., GoodmanR., and SnyderS. H. (1975): “An Endogenous Morphine-like Factor in Mammalian Brain”, Life Sci., 16, 1765.
50.
PertC. B., and SnyderS. H. (1973a): “Opiate Receptor: Demonstration in Nervous Tissue”, Science, 179, 1011.
51.
PertC. B., and SnyderS. H. (1973b): “Properties of Opiate Receptor Binding in Rat Brain”, Proc. Nat. Acad. Sci. USA, 70, 2243.
52.
PertC. B., and SnyderS. H. (1974): “Opiate Receptor Binding of Agonists and Antagonists Affected Differentially by Sodium”, Mol. Pharmacol., 10, 868.
53.
PertC. B., PertA., and TallmanJ. F. (1976): Isolation of a Novel Endogenous Opiate Analgesic from Human Blood”, Proc. Nat. Acad. Sci. USA, 73, 2226.
54.
RoyA. C., and CollierH. O. J. (1975): “Prostaglandins, Cyclic AMP and the Biochemical Mechanism of Opiate Agonist Action”, Life Sci., 16, 1857.
55.
SharmaS. K., NirenbergM., and KleeW. A. (1975): “Morphine Receptors as Regulators of Adenylate Cyclase Activity”, Proc. Nat. Acad. Sci. USA, 72, 590.
56.
SimantovR., and SnyderS. H. (1976a): “Isolation and Structure Identification of a Morphine-like Peptide ‘Enkephalin’ in Bovine Brain”, Life Sci., 18, 781.
57.
SimantovR., and SnyderS. H. (1976b): “Morphinelike Peptides in Mammalian Brain: Isolation, Structure Elucidation, and Interactions with the Opiate Receptor”, Proc. Nat. Acad. Sci. USA, 73, 2515.
58.
SimonE. J., HillerJ. M., and EdelmanI. (1973): “Stereospecific Binding of the Potent Narcotic Analgesic [3H] Etorphine to Rat Brain Homogenate”, Proc. Nat. Acad. Sci. USA, 70, 1947.
59.
SnyderS. H. (1975): “A Model of Opiate Receptor Function with Implications for a Theory of Addiction”, Neurosciences Res. Prog. Bull., 13, 1, 137.
TereniusL. (1973a): “Stereospecific Interaction Between Narcotic Analgesics and a Synaptic Plasma Membrane Fraction of Rat Cerebral Cortex”, Acta Pharmacol. Toxicol., 32, 317.
62.
TereniusL. (1973b): “Characteristics of the ‘Receptor’ for Narcotic Analgesics in Synaptic Plasma Membrane Fraction from Rat Brain”, Acta Pharmacol. Toxicol., 33, 377.
63.
TereniusL., and WahlströmA. (1974): “Inhibitor(s) of Narcotic Receptor Binding in Brain Extracts and Cerebrospinal Fluid”, Acta Pharmacol. Toxicol., 35 (Suppl.), 55.
64.
TereniusL., and WahlströmA. (1975a): “Search for an Endogenous Ligand for the Opiate Receptor”, Acta Physiol. Scand., 94, 74.
65.
TereniusL., and WahlströmA. (1975b): “Morphinelike Ligand for Opiate Receptors in Human C.S.F.”, Life Sci., 16, 1759.
66.
TeschenmakerH., OpheimK. E., CoxB. M., and GoldsteinA. (1975): “A Peptide-like Substance from Pituitary that Acts Like Morphine: Isolation”, Life Sci., 16, 1771.
67.
TraberJ., FisherK., LatzinS., and HamprechtB. (1975): “Morphine Antagonizes Action of Prostaglandin in Neuroblastoma and Neuroblastoma x Glioma Hybrid Cells”, Nature, 253, 120.
68.
TraberJ., GullisR., and HamprechtB. (1975): “Influence of Opiates on the Levels of Adenosine 31: 51-Cyclic Monophosphate in Neuroblastoma x Glioma Hybrid Cells”, Life Sci., 16, 1863.
69.
WaterfieldA. A., HughesJ., and KosterlitzH. W. (1976): “Cross Tolerance Between Morphine and Methionine-Enkephalin”, Nature, 260, 624.
70.
WilsonH. A., PasternakG. W., and SnyderS. H. (1975): “Differentiation of Opiate Agonist and Antagonist Receptor Binding by Protein Modifying Reagents”, Nature, 253, 448.
71.
WongD. T., and HorngJ. S. (1973): “Stereospecific Interaction of Opiate Narcotics in Binding of 3H-Dihydromorphine to Membranes of Rat Brain”, Life Sci., 13, 1543.
72.
YakshT. L., YeungJ. C., and RudyT. A. (1976): “An Inability to Antagonise with Naloxone the Elevated Nociceptive Thresholds Resulting from Electrical Stimulation of the Mesencephalic Grey”, Life Sci., 18, 1193.
